BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34263360)

  • 21. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society.
    Hayasaki A; Mizuno S; Nagata M; Kaluba B; Maeda K; Shinkai T; Ito T; Gyoten K; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kuriyama N; Isaji S; Kishiwada M
    HPB (Oxford); 2023 Oct; 25(10):1268-1277. PubMed ID: 37419780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
    Park SJ; Kim JH; Joo I; Lee KB; Han JK
    Eur Radiol; 2021 Jun; 31(6):3616-3626. PubMed ID: 33201279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.
    Li D; Wang L; Cai W; Liang M; Ma X; Zhao X
    Eur J Radiol; 2022 Jun; 151():110313. PubMed ID: 35447500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractal analysis improves tumour size measurement on computed tomography in pancreatic ductal adenocarcinoma: comparison with gross pathology and multi-parametric MRI.
    Michallek F; Haouari MA; Dana O; Perrot A; Silvera S; Dallongeville A; Dewey M; Zins M
    Eur Radiol; 2022 Aug; 32(8):5053-5063. PubMed ID: 35201407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
    Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
    Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival Prediction after Curative Resection of Pancreatic Ductal Adenocarcinoma by Imaging-Based Intratumoral Necrosis.
    Kim H; Kim DH; Song IH; Kim B; Oh SN; Choi JI; Rha SE
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma.
    Dal Molin M; Blackford AL; Siddiqui A; Brant A; Cho C; Rezaee N; Yu J; He J; Weiss M; Hruban RH; Wolfgang C; Goggins M
    Ann Surg Oncol; 2017 Aug; 24(8):2379-2386. PubMed ID: 28439733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.
    Cassinotto C; Chong J; Zogopoulos G; Reinhold C; Chiche L; Lafourcade JP; Cuggia A; Terrebonne E; Dohan A; Gallix B
    Eur J Radiol; 2017 May; 90():152-158. PubMed ID: 28583627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
    Nagayama Y; Tanoue S; Inoue T; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
    Eur Radiol; 2020 Jan; 30(1):394-403. PubMed ID: 31312889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma.
    Khalvati F; Zhang Y; Baig S; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA
    Sci Rep; 2019 Apr; 9(1):5449. PubMed ID: 30931954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.
    Hyun SH; Kim HS; Choi SH; Choi DW; Lee JK; Lee KH; Park JO; Lee KH; Kim BT; Choi JY
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1461-8. PubMed ID: 26872788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis.
    Eilaghi A; Baig S; Zhang Y; Zhang J; Karanicolas P; Gallinger S; Khalvati F; Haider MA
    BMC Med Imaging; 2017 Jun; 17(1):38. PubMed ID: 28629416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
    Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
    Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma.
    Wang L; Wu H; Wang L; Lu J; Duan H; Liu X; Liang Z
    Diagn Pathol; 2016 Jul; 11(1):60. PubMed ID: 27391842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.
    Choi SH; Kim HJ; Kim KW; An S; Hong SM; Kim SC; Kim MH
    Br J Radiol; 2017 May; 90(1073):20160403. PubMed ID: 28339284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.